AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile
AD/PD - Advances in Science & Therapy

@adpdnet

AD/PD™ 2026: Striving for a better future for all those affected by neurodegenerative diseases.
March 17-21 | Copenhagen, Denmark
#KenesOriginalEvents

ID: 3058625465

linkhttps://adpd.kenes.com/ calendar_today24-02-2015 10:53:10

6,6K Tweet

4,4K Followers

1,1K Following

AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

Norepinephrine’s powerful effects in the brain are largely orchestrated by astrocytes, not neurons. A trio of new studies reveals how these “gatekeepers” fine-tune thousands of synapses via adrenergic receptors, while neurons might just be along for the ride. Astrocytes release

AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

🎥 You can relive the highlights of #ADPD2025 until October 5, 2025! All sessions from the AD/PD™ 2025 International Conference are now available on demand through the UNLOK virtual platform. 🧠 Dive back into groundbreaking research, clinical insights and global discussions

🎥 You can relive the highlights of #ADPD2025 until October 5, 2025! All sessions from the AD/PD™ 2025 International Conference are now available on demand through the UNLOK virtual platform.

🧠 Dive back into groundbreaking research, clinical insights and global discussions
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

🎧 New AD/PD™ Session Spotlight out now! In this episode, Jeffrey Cummings breaks down the current state of the #Alzheimers disease drug development pipeline - from biomarker breakthroughs to emerging therapeutic targets and global trial trends. If you're involved in drug

🎧 New AD/PD™ Session Spotlight out now!

In this episode, <a href="/DrJeffCummings/">Jeffrey Cummings</a> breaks down the current state of the #Alzheimers disease drug development pipeline - from biomarker breakthroughs to emerging therapeutic targets and global trial trends.

If you're involved in drug
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

🧠 Join the Next AD/PD™ Live Journal Club of 2025! Discover how subtle behavioral cues, like response time—even when test scores seem normal—may help detect early signs of Alzheimer’s and other dementias. Topic: "Precision Neurocognition: A New Diagnostic Paradigm in

🧠 Join the Next AD/PD™ Live Journal Club of 2025!

Discover how subtle behavioral cues, like response time—even when test scores seem normal—may help detect early signs of Alzheimer’s and other dementias.

Topic: "Precision Neurocognition: A New Diagnostic Paradigm in
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

We're inviting researchers to submit abstracts on β-Amyloid Diseases for #ADPD2026! Share your innovative findings and insights with the global #neuroscience community. This is your chance to contribute to advancing neurodegenerative disease research and make a lasting

We're inviting researchers to submit abstracts on β-Amyloid Diseases for #ADPD2026! 
 
Share your innovative findings and insights with the global #neuroscience community. This is your chance to contribute to advancing neurodegenerative disease research and make a lasting
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

Meet Prof. George Perry at the next AD/PD™ Live Journal Club - "Precision Neurocognition: A New Diagnostic Paradigm in Alzheimer’s Detection"! 📅 When: 1 July at 16:00 CEST 🎤 Prof. George Perry and Prof. David Libon 👉 REGISTER NOW: bit.ly/3ZAF9bb 📖 Bonus: FREE

Meet Prof. George Perry at the next AD/PD™ Live Journal Club - "Precision Neurocognition: A New Diagnostic Paradigm in Alzheimer’s Detection"!

📅 When: 1 July at 16:00 CEST
🎤 Prof. George Perry and Prof. David Libon
👉 REGISTER NOW: bit.ly/3ZAF9bb

📖 Bonus: FREE
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

📰 Do PERK’d Up Astrocytes Slow Amyloid Clearance? | Alzforum “Cells feature an array of biological cascades to respond to stressors such as protein aggregates, viruses, and #DNA damage. When these pathways are activated too much or for too long, things can go awry. This may

📰 Do PERK’d Up Astrocytes Slow Amyloid Clearance? | <a href="/alzforum/">Alzforum</a> 

“Cells feature an array of biological cascades to respond to stressors such as protein aggregates, viruses, and #DNA damage. When these pathways are activated too much or for too long, things can go awry. This may
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

🎧 New AD/PD™ Session Spotlight out now! In this episode, we dive into one of the most forward-looking conversations from the AD/PD™ 2025 International Conference — "Integrating Blood-Based, CSF and Imaging Biomarkers With Digital Tools and #AI in MCI & AD." Moderated by

🎧 New AD/PD™ Session Spotlight out now!

In this episode, we dive into one of the most forward-looking conversations from the AD/PD™ 2025 International Conference — "Integrating Blood-Based, CSF and Imaging Biomarkers With Digital Tools and #AI in MCI &amp; AD."
 
Moderated by
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

🧠 Join our FREE AD/PD™ Webinar: Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression 🧠 📅 26 June 2025 | 10:00 EST, 16:00 CEST 🔍Explore amyloid-tau dynamics in AD with Dr. Niklas Mattsson-Carlgren, of Lund University and a live Q&A with Dr. Holly

🧠 Join our FREE AD/PD™ Webinar: Amyloid and Tau in Alzheimer’s Disease: Insights into Disease Progression 🧠

📅 26 June 2025 | 10:00 EST, 16:00 CEST
🔍Explore amyloid-tau dynamics in AD with Dr. Niklas Mattsson-Carlgren, of Lund University and a live Q&amp;A with Dr. Holly
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

Share your cutting-edge research on tauopathies for #ADPD2026!💡 Join the global effort to unravel the complexities of tau-related #neurodegeneration and drive forward innovative treatments. Submit your abstracts now➡️ adpd.kenes.com/abstract-submi… #ADPD #alzheimers #dementia

Share your cutting-edge research on tauopathies for #ADPD2026!💡

Join the global effort to unravel the complexities of tau-related #neurodegeneration and drive forward innovative treatments. Submit your abstracts now➡️ adpd.kenes.com/abstract-submi…  
#ADPD #alzheimers #dementia
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

Meet Prof. David J. Libon, Ph.D. at the upcoming AD/PD™ Live Journal Club - "Precision Neurocognition: A New Diagnostic Paradigm in Alzheimer’s Detection"! 📅 When: 1 July at 16:00 CEST 🎤 Prof. George Perry and Prof. David Libon 👉 REGISTER NOW: bit.ly/3ZAF9bb 📖

Meet Prof. David J. Libon, Ph.D. at the upcoming AD/PD™ Live Journal Club - "Precision Neurocognition: A New Diagnostic Paradigm in Alzheimer’s Detection"!

📅 When: 1 July at 16:00 CEST
🎤 Prof. George Perry and Prof. David Libon
👉 REGISTER NOW: bit.ly/3ZAF9bb

📖
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

📰 Could Monocyte-Derived Microglia Cause Some Cases of Parkinsonism? “Microglia in the brain’s parenchyma arise from macrophage progenitors in the embryonic yolk sac and are thought to self-renew locally during a mammal’s lifespan, without macrophages from the hematopoietic

📰 Could Monocyte-Derived Microglia Cause Some Cases of Parkinsonism? 

“Microglia in the brain’s parenchyma arise from macrophage progenitors in the embryonic yolk sac and are thought to self-renew locally during a mammal’s lifespan, without macrophages from the hematopoietic
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

📢 Last Call! You still have time to secure your spot for tomorrow's AD/PD™ Journal Club! 📅 When: 1 July at 16:00 CEST 🎤 Prof. George Perry and Prof. David Libon 👉 REGISTER NOW: bit.ly/43NjBdW Bonus: FREE access to the featured publication for all attendees:

📢 Last Call!
You still have time to secure your spot for tomorrow's AD/PD™ Journal Club!

📅 When: 1 July at 16:00 CEST
🎤 Prof. George Perry and Prof. David Libon
👉 REGISTER NOW: bit.ly/43NjBdW

Bonus: FREE access to the featured publication for all attendees:
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

Dive deep into the world of Parkinson's disease, multiple system atrophy, and other #synucleinopathies. Join us in advancing the understanding and treatment of these complex disorders. Submit your abstracts by September 10, 2025, and be a part of the discussion at #ADPD2026!🔗

Dive deep into the world of Parkinson's disease, multiple system atrophy, and other #synucleinopathies. Join us in advancing the understanding and treatment of these complex disorders. 
Submit your abstracts by September 10, 2025, and be a part of the discussion at #ADPD2026!🔗
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

🧠 Discover how a multimodal intervention—combining lifestyle changes with medical food—can improve outcomes for older adults at risk of #Alzheimers. 🎥 Watch this video to explore: bit.ly/4lAE1gn ✔️ Key findings from a recent study ✔️ Real participant feedback ✔️ The

🧠 Discover how a multimodal intervention—combining lifestyle changes with medical food—can improve outcomes for older adults at risk of #Alzheimers.

🎥 Watch this video to explore: bit.ly/4lAE1gn

✔️ Key findings from a recent study
✔️ Real participant feedback
✔️ The
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

The application for AD/PD™ 2026 Junior Faculty Awards is open! If you're an early-career researcher eager to make your mark, this is your chance to shine. Submit your application by September 17, 2025, to be considered for this prestigious recognition and join us in

The application for AD/PD™ 2026 Junior Faculty Awards is open! 

If you're an early-career researcher eager to make your mark, this is your chance to shine. Submit your application by September 17, 2025, to be considered for this prestigious recognition and join us in
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

Share your findings at AD/PD™ 2026! Be part of the conversation in Copenhagen, Denmark, and contribute to the global effort to understand and combat neurodegenerative diseases. 📆 Abstract Submission Deadline: September 10, 2025. Submit your abstract here: 🔗

Share your findings at AD/PD™ 2026!

Be part of the conversation in Copenhagen, Denmark, and contribute to the global effort to understand and combat neurodegenerative diseases. 
📆 Abstract Submission Deadline: September 10, 2025. 
Submit your abstract here: 🔗
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

🎧 New AD/PD™ Session Spotlight out now! In this episode, we explore Plenary Lecture 2 from #ADPD2025: “GLP-1R Agonist Effects in Brain.” Moderated by Dr. Cynthia Lemere | Cynthia Lemere and Dr. Henrietta Nielsen, this featured lecture was presented by Dr. Lotte Bjerre Knudsen

🎧 New AD/PD™ Session Spotlight out now!

In this episode, we explore Plenary Lecture 2 from #ADPD2025: “GLP-1R Agonist Effects in Brain.”

Moderated by Dr. Cynthia Lemere | <a href="/clemere99/">Cynthia Lemere</a> and Dr. Henrietta Nielsen, this featured lecture was presented by Dr. Lotte Bjerre Knudsen
AD/PD - Advances in Science & Therapy (@adpdnet) 's Twitter Profile Photo

🎥 Reminder: All sessions from the AD/PD™ 2025 International Conference are available on demand through the UNLOK virtual platform for all registered Gold Track participants! Dive back into cutting-edge research, clinical insights, and global discussions, all from the

🎥 Reminder: All sessions from the AD/PD™ 2025 International Conference are available on demand through the UNLOK virtual platform for all registered Gold Track participants! 

Dive back into cutting-edge research, clinical insights, and global discussions, all from the